Cargando…

Phenotypic Variability in Huntington's Disease

Detalles Bibliográficos
Autores principales:	Chouksey, Anjali, Pandey, Sanjay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061502/ https://www.ncbi.nlm.nih.gov/pubmed/32189853 http://dx.doi.org/10.4103/aian.AIAN_543_19

Ejemplares similares

Clinical Spectrum of Drug-Induced Movement Disorders: A Study of 97 Patients
por: Chouksey, Anjali, et al.
Publicado: (2020)

Reply – Clinical Spectrum of Drug-Induced Movement Disorders: A Study of 97 Patients
por: Chouksey, Anjali, et al.
Publicado: (2020)

Functional Movement Disorders in Children
por: Chouksey, Anjali, et al.
Publicado: (2020)

Functional Movement Disorders in Elderly
por: Chouksey, Anjali, et al.
Publicado: (2019)

Rectifying rectifier channels in Huntington disease
por: Proft, Juliane, et al.
Publicado: (2014)

Synaptopathy, circuitopathy and the computational biology of Huntington’s disease
por: Hannan, Anthony J.
Publicado: (2018)

Implications of the Orb2 Amyloid Structure in Huntington’s Disease
por: Hervás, Rubén, et al.
Publicado: (2020)

Huntington’s disease skeletal muscle has altered T-tubules
por: Khan, Muhammad S., et al.
Publicado: (2021)

A shared mechanism of muscle wasting in cancer and Huntington’s disease
por: Mielcarek, Michal, et al.
Publicado: (2015)

Molecular Research on Huntington’s Disease
por: Valor, Luis M.
Publicado: (2023)

Compensation in the course of Huntington's disease — More than just a hypothesis?
por: Schiefer, Johannes
Publicado: (2015)

Neural Compensation in Huntington's Disease: Teaching Mental Disorders New Tricks?
por: Wolf, Robert Christian, et al.
Publicado: (2015)

Trojan triplets: RNA-based pathomechanisms for muscle dysfunction in Huntington’s disease
por: Skov, Martin, et al.
Publicado: (2017)

Profile of pridopidine and its potential in the treatment of Huntington disease: the evidence to date
por: Squitieri, Ferdinando, et al.
Publicado: (2015)

Supporting Huntington’s Disease Families Through the Ups and Downs of Clinical Trials
por: Andrew, Kelly M., et al.
Publicado: (2023)

Resurrection of sildenafil: potential for Huntington’s Disease, too?
por: Achenbach, Jannis, et al.
Publicado: (2022)

Skeletal Muscle Modulates Huntington’s Disease Pathogenesis in Mice: Role of Physical Exercise
por: Corrochano, Silvia, et al.
Publicado: (2018)

Raising Awareness of Therapeutic Misconception and Optimism Around Clinical Trials in Huntington’s Disease
por: de Bot, Susanne Tamara
Publicado: (2019)

Conclusions of the SIGNAL study in Huntington and implications for treatment of other slowly progressive neurodegenerative diseases
por: Zauderer, Maurice, et al.
Publicado: (2023)

Huntington's disease: of mice and men
por: Yhnel, Emma
Publicado: (2017)

Special Issue: Juvenile Onset Huntington’s Disease
por: Nopoulos, Peg C.
Publicado: (2020)

Molecule of the month: miRNA and Huntington's disease (HD)
por: Shapshak, Paul
Publicado: (2013)

Understanding histone deacetylation in Huntington’s disease
por: Valor, Luis Miguel
Publicado: (2016)

Influence of Age of Onset on Huntington’s Disease Phenotype
por: Kwa, Lauren, et al.
Publicado: (2020)

p75(NTR) in Huntington's disease: beyond the basal ganglia
por: Brito, Verónica, et al.
Publicado: (2015)

Preface to the Special Issue on “Sleep and Circadian Disorder in Huntington’s Disease”
por: Leavitt, Blair R., et al.
Publicado: (2023)

Introduction to the Special Issue on Sleep and Circadian Rhythms in Huntington’s Disease
por: Morton, Jenny
Publicado: (2023)

Cerebrospinal fluid levels of proenkephalin and prodynorphin are differentially altered in Huntington’s and Parkinson’s disease
por: Barschke, Peggy, et al.
Publicado: (2022)

Chorea me a river: depression in Huntington’s disease as an exemplar of precision medicine
por: Hannan, Anthony J
Publicado: (2022)

Gait variability as digital biomarker of disease severity in Huntington’s disease
por: Gaßner, Heiko, et al.
Publicado: (2020)

Phenotypic Variability in Phelan–McDermid Syndrome and Its Putative Link to Environmental Factors
por: Boccuto, Luigi, et al.
Publicado: (2022)

Striatal Network Models of Huntington's Disease Dysfunction Phenotypes
por: Zheng, Pengsheng, et al.
Publicado: (2017)

Prominent Jaw Closure Dystonia, Awake Bruxism, and Stereotypies in a Patient with Hypoglycemic Encephalopathy
por: Vijayaraghavan, Asish, et al.
Publicado: (2022)

Novel Therapeutic Approach to Induce Autophagy in a Drosophila Model for Huntington’s Disease
por: Martinez-Vicente, Marta
Publicado: (2020)

Correction to: Gait variability as digital biomarker of disease severity in Huntington’s disease
por: Gaßner, Heiko, et al.
Publicado: (2020)

Huntington’s Disease Outpatient Clinic for Functional Diagnosis and Treatment: Coming to Consensus: How Long Term Care Facility Procedures Complement Specialist Diagnosis and Treatment
por: Veenhuizen, Ruth, et al.
Publicado: (2018)

Targeting the equilibrative nucleoside transporter ENT1 in Huntington disease
por: Guitart, Xavier, et al.
Publicado: (2017)

Interleukin-6 deficiency exacerbates Huntington’s disease model phenotypes
por: Wertz, Mary H., et al.
Publicado: (2020)

Temporal Phenotypic Changes in Huntington’s Disease Models for Preclinical Studies
por: St-Cyr, Sophie, et al.
Publicado: (2022)

Amelioration of Huntington’s disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington’s disease monkeys
por: Cho, In Ki, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kd1f9p6o2siv1f066jv8dqkrme